M3, Inc. (TYO:2413)
2,114.00
+13.00 (0.62%)
At close: Dec 30, 2025
M3, Inc. Market Cap
M3, Inc. has a market cap or net worth of 1.43 trillion as of January 2, 2026. Its market cap has increased by 40.75% in one year.
Market Cap
1.43T
Enterprise Value
1.37T
Revenue
330.97B
Ranking
n/a
PE Ratio
31.26
Stock Price
2,114.00
Market Cap Chart
Since September 16, 2004, M3, Inc.'s market cap has increased from 53.60B to 1.43T, an increase of 2,571.96%. That is a compound annual growth rate of 16.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.43T | 50.98% |
| Dec 30, 2024 | 948.61B | -40.12% |
| Dec 29, 2023 | 1.58T | -34.79% |
| Dec 30, 2022 | 2.43T | -38.22% |
| Dec 30, 2021 | 3.93T | -40.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.57T |
| HOYA Corporation | 8.01T |
| Takeda Pharmaceutical Company | 7.64T |
| Daiichi Sankyo Company | 6.20T |
| Otsuka Holdings | 4.69T |
| Astellas Pharma | 3.75T |
| Terumo | 3.35T |
| Shionogi & | 2.42T |